A Catalyst for Curbing the Diabetes Epidemic in Germany

The Helmholtz Diabetes Center is a four-story, multidisciplinary bioscientific research center dedicated to diabetes research. The Biosafety Level 2 research facility enables basic research, translational research, epidemiology and clinical applications. With around six million diagnosed diabetes cases and an equally high number of estimated unreported cases in Germany, the facility acts as a catalyst for curbing the diabetes epidemic in Germany.

In addition to providing the best possible infrastructure for research work, the facility is also intended to promote interaction and communication between the scientists of the various institutes and working groups. The design concept for the building prioritizes optimal arrangement of the functions and efficient use of space via a sophisticated and dynamic architecture. The architecture is a spatial expression of contemporary and sustainable process planning.